Bifunctional Au–Fe3O4 Nanoheterodimers Acting as X-ray Protector in Healthy Cells and as X-ray Enhancer in Tumor Cells
Source abstract
Abstract
Bifunctional Au–Fe3O4 nanoheterodimers were synthesized by thermally decomposing Fe(III)oleate on gold nanoparticles followed by functionalizing with tiron, 2,3-dihydroxybenzoic acid, or caffeic acid. These catechol derivatives are antioxidative and thus are predicted to function as superoxide scavengers. In particular, caffeic acid lost its antioxidant capacity, although it was covalently linked through its carboxyl moiety to the Fe3O4 surface. Tiron was shown to bind via its catechol group to the Au–Fe3O4 nanoheterodimers, and 2,3-dihydroxybenzoic was just physisorbed between the oleic acid surface structures. Caffeic-acid stabilized Au–Fe3O4 nanoheterodimers turned out to act as X-ray protector in healthy cells but as X-ray enhancing agents in cancer cells. Furthermore, these functionalized Au–Fe3O4 nanoheterodimers were found to inhibit the migratory capacity of the cancer cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Free Radicals and Antioxidants · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Pharmacy, Physical Chemistry I and ICMM, Friedrich-Alexander University of Erlangen, Egerlandstraße 3, D-91058 Erlangen, Germany
Department of Radiation Oncology, Friedrich-Alexander University of Erlangen, Universitätsstraße 27, D-91054 Erlangen, Germany
References (53)
Show source-provided references
1. 10.1038/nrc195010.1038/nrc1950 ↗
2. Rehman M. U. · Radiat. Environ. Med. · 2016 · 5 · 40
3. 10.1667/RR14186.110.1667/RR14186.1 ↗
4. 10.1517/1354377090282417210.1517/13543770902824172 ↗
5. 10.1269/jrr.43.S1310.1269/jrr.43.S13 ↗
6. 10.1517/1354377090296766610.1517/13543770902967666 ↗
7. 10.1080/0955300941455004110.1080/09553009414550041 ↗
8. 10.1093/jnci/djn14810.1093/jnci/djn148 ↗
9. 10.1038/nrd280310.1038/nrd2803 ↗
10. 10.1016/j.biomaterials.2011.09.04710.1016/j.biomaterials.2011.09.047 ↗
11. 10.1089/ars.2012.500010.1089/ars.2012.5000 ↗
12. Butterworth K. T. · Transl. Cancer Res. · 2013 · 2 · 269
13. 10.1667/RR1984.110.1667/RR1984.1 ↗
14. 10.1039/c2nr31227a10.1039/c2nr31227a ↗
15. 10.1211/jpp.60.8.000510.1211/jpp.60.8.0005 ↗
16. 10.1016/j.rpor.2010.09.00110.1016/j.rpor.2010.09.001 ↗
17. 10.1039/c3nr00333g10.1039/c3nr00333g ↗
18. 10.1016/j.addr.2015.12.01210.1016/j.addr.2015.12.012 ↗
19. 10.2217/nnm.14.5510.2217/nnm.14.55 ↗
20. 10.1016/j.nano.2011.01.01410.1016/j.nano.2011.01.014 ↗
21. 10.1021/acsami.8b0366010.1021/acsami.8b03660 ↗
22. 10.1021/acsabm.8b0051110.1021/acsabm.8b00511 ↗
23. 10.1016/j.bbrc.2012.07.10810.1016/j.bbrc.2012.07.108 ↗
24. 10.1021/jp502622410.1021/jp5026224 ↗
25. 10.1002/smll.20170411110.1002/smll.201704111 ↗
26. 10.1021/acs.langmuir.6b0364410.1021/acs.langmuir.6b03644 ↗
27. 10.5530/ax.2012.4.1110.5530/ax.2012.4.11 ↗
28. 10.1155/2008/95369210.1155/2008/953692 ↗
29. Karamac M. · Polym. J. Food Nutr. Sci. · 2005 · 14 · 165
30. 10.1039/C4RA13315C10.1039/C4RA13315C ↗
31. Petkau A. · Br. J. Cancer · 1987 · 55 · 87
32. 10.1269/jrr.1103410.1269/jrr.11034 ↗
33. 10.1667/RR308110.1667/RR3081 ↗
34. 10.1002/cbf.281710.1002/cbf.2817 ↗
35. 10.25011/cim.v31i5.487010.25011/cim.v31i5.4870 ↗
36. 10.1269/jrr.45.25310.1269/jrr.45.253 ↗
37. 10.1155/2014/14534210.1155/2014/145342 ↗
38. 10.1007/s00280-005-0066-810.1007/s00280-005-0066-8 ↗
39. 10.1007/s11010-010-0655-710.1007/s11010-010-0655-7 ↗
40. 10.1016/S1028-4559(10)60092-710.1016/S1028-4559(10)60092-7 ↗
41. 10.1021/jp810247u10.1021/jp810247u ↗
42. 10.1039/c1nr10173k10.1039/c1nr10173k ↗
43. 10.1021/acs.langmuir.6b0349110.1021/acs.langmuir.6b03491 ↗
44. 10.1038/nrc171310.1038/nrc1713 ↗
45. 10.1089/ars.2013.548910.1089/ars.2013.5489 ↗
46. 10.1023/A:100635733048610.1023/A:1006357330486 ↗
47. 10.1016/j.canlet.2008.02.03110.1016/j.canlet.2008.02.031 ↗
48. Ivanova D. · Adv. Clin. Exp. Med. · 2013 · 22 · 899
49. 10.1038/nprot.2008.22610.1038/nprot.2008.226 ↗
50. 10.1186/1479-5876-4-1210.1186/1479-5876-4-12 ↗
51. 10.2174/138161281966613112515043410.2174/1381612819666131125150434 ↗
52. 10.1016/j.ab.2004.03.04910.1016/j.ab.2004.03.049 ↗
53. 10.1038/nprot.2006.33910.1038/nprot.2006.339 ↗